This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
Array BioPharma Inc
ARRY : NASDAQ : Health Care
$3.48 | %
Today's Range: 0.00 - 0.00
Avg. Daily Volume: 1,193,300
10/21/14 - 4:00 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
ARRY ARRAY BIOPHARMA INC 3.45 454.81 n/m 42.08 -39.53
OREX OREXIGEN THERAPEUTICS INC 4.19 513.42 n/m 3.43 0.00
TKMR TEKMIRA PHARMACEUTICALS CORP 22.81 504.24 n/m 16.81 39.51
SPPI SPECTRUM PHARMACEUTICALS INC 7.55 496.28 n/m 170.93 -15.98
ONVO ORGANOVO HOLDINGS INC 6.21 487.36 n/m 0.37 -68.56
HPTX HYPERION THERAPEUTICS INC 22.17 456.66 24.63 90.69 1021.32
OSIR OSIRIS THERAPEUTICS INC 13.19 452.55 n/m 38.31 165.42
FOLD AMICUS THERAPEUTICS INC 5.66 445.45 n/m 1.29 n/a
XOMA XOMA CORP 4.07 435.08 n/m 28.23 -9.66
RNA PROSENSA HOLDING NV 11.13 401.75 n/m 28.16 954.21
DVAX DYNAVAX TECHNOLOGIES CORP 1.49 391.69 n/m 12.32 21.29
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

ARRY Ind Avg S&P 500
n/m 79.53 18.06
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades


Top Rated Stocks Top Rated Funds Top Rated ETFs